ConductScience.org, home

Paper38461908

Pyroptosis in myocardial ischemia/reperfusion and its therapeutic implications.

Liu Y and 4 others. Eur J Pharmacol, 2024. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Pyroptosis in myocardial ischemia/reperfusion and its therapeutic implications. Papers, record 38461908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38461908

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pyroptosis in myocardial ischemia/reperfusion and its therapeutic implications.
PubMed
Journal
Eur J Pharmacol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
4.86, provisional
iCite
Revised in PubMed
2024-04-22
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu YYin
2Li XXi
3Sun TTingting
4Li TTao
5Li QQian

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Myocardial Reperfusion InjuryMajor topic
Reperfusion InjuryMajor topic
Humans
Pyroptosis
Inflammasomes
Ischemia
Reperfusion
NLR Family, Pyrin Domain-Containing 3 Protein

Source PubMed

Download CSV of topics

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
42939749The DAMP Awakens: The Role of Heme and Heme Oxygenase-1 in Organ Transplantation.Biomolecules2026https://conductscience.org/library/papers/42939749PubMed
42662069Decoding the molecular mechanisms of pyroptosis and its therapeutic development prospects.Front Cell Dev Biol2026https://conductscience.org/library/papers/42662069PubMed
42534140Potential Relationship Between Ferroptosis and Pyroptosis in Myocardial Ischemia/Reperfusion Injury: Molecular Mechanisms and Therapeutic Targets.Rev Cardiovasc Med2026https://conductscience.org/library/papers/42534140PubMed
42517156Bibliometric Trends in Inflammasome‑Driven Pyroptosis and Cardiovascular Disease.J Inflamm Res2026https://conductscience.org/library/papers/42517156PubMed
42305535Electroacupuncture alleviates myocardial ischemia-reperfusion injury by targeting and inhibiting NLRP3 inflammasome-mediated cardiomyocyte pyroptosis via serum exosomal miR-22-3p.Front Immunol2026https://conductscience.org/library/papers/42305535PubMed
42004515Delta opioid peptide (D-Ala2, D-Leu5)-enkephalin (DADLE) mitigates myocardial ischemia-reperfusion injury by inhibiting the TRAF6/NF-κB/NLRP3 pathway.Iran J Basic Med Sci2026https://conductscience.org/library/papers/42004515PubMed
42004242Research Progress of Nerve Injury-Induced Protein 1 in Cardiovascular Diseases.Cardiol Res Pract2026https://conductscience.org/library/papers/42004242PubMed
41826966Salvigenin alleviates ferroptosis and pyroptosis in myocardial ischemia/reperfusion models by inhibiting the NLRP3 pathway.Biomed Eng Online2026https://conductscience.org/library/papers/41826966PubMed
41575474BMP7 attenuates myocardial injury and preserves cardiac function after myocardial infarction by inhibiting cardiomyocyte pyroptosis.Apoptosis2026https://conductscience.org/library/papers/41575474PubMed
41378869Mechanism of Hypoxia-Induced HMGB1 Regulating NLRP3 Inflammasome/Caspase-1 Pathway-Mediated Pyroptosis in Myocardial Ischemia Reperfusion Injury Through the Nrf2/HO-1 Pathway.CNS Neurosci Ther2025https://conductscience.org/library/papers/41378869PubMed
41252094Cell death forms in myocardial ischemia-reperfusion injury and their potential clinical applications.Mol Cell Biochem2026https://conductscience.org/library/papers/41252094PubMed
41160375Emerging Dual Roles of ALKBH5 in Ischemia-reperfusion Injury: Mechanisms and Therapeutic Implications.Cell Biochem Biophys2026https://conductscience.org/library/papers/41160375PubMed
41113142Estrogen Alleviates Myocardial Ischemia-Reperfusion Injury by Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis.Cardiol Res Pract2025https://conductscience.org/library/papers/41113142PubMed
40779176Butyrate protects against myocardial ischemia injury and cardiomyocyte pyroptosis by inhibiting MALT1-mediated Nrf2 ubiquitination and degradation.J Mol Histol2025https://conductscience.org/library/papers/40779176PubMed
40717825Sevoflurane Alleviates Cardiomyocyte Ferroptosis via Ubiquitin-Specific Protease 7/Phosphatase and Tensin Homolog Modulation.Drug Des Devel Ther2025https://conductscience.org/library/papers/40717825PubMed
40391625Salvia miltiorrhiza-derived exosome-like nanoparticles improve diabetic cardiomyopathy by inhibiting NLRP3 inflammasome-mediated macrophage pyroptosis via targeting the NEDD4/SGK1 axis.Nanomedicine (Lond)2025https://conductscience.org/library/papers/40391625PubMed
40227195Endothelial Dysfunction: Redox Imbalance, NLRP3 Inflammasome, and Inflammatory Responses in Cardiovascular Diseases.Antioxidants (Basel)2025https://conductscience.org/library/papers/40227195PubMed
40094786A study on the molecular mechanism of cardiac protection of procarboxylpeptidase in MIRI rats based on the NLRP3 signaling pathway.Sci Prog2025https://conductscience.org/library/papers/40094786PubMed
39886966Remimazolam alleviates myocardial ischemia/reperfusion injury and inflammation via inhibition of the NLRP3/IL‑1β pathway in mice.Int J Mol Med2025https://conductscience.org/library/papers/39886966PubMed
39575347Diltiazem Hydrochloride Protects Against Myocardial Ischemia/Reperfusion Injury in a BNIP3L/NIX-Mediated Mitophagy Manner.J Inflamm Res2024https://conductscience.org/library/papers/39575347PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38461908

GET https://conductscience.org/api/papers/v1/38461908/cited_by?page=2